The bus that goes up to Pellam House leaves the valley station at ten past six in the morning and it is not a medical vehicle. It is a coach with soft seats and a working heater, and somebody at the program decided a long time ago that the last journey a person makes under their own arrangements should not smell like a clinic. There are nine of us on it. I am the youngest by about fifteen years and the only one with a bag that has been packed for eleven days rather than for the rest of a life.

I am enrolled as Renna Cole, drought build, commercial stock, forty-one, out of a district that does not keep good records. The label is not mine. My own build is bespoke, lynx template, and my numbers are bad but they are bad in the expensive way, which is to say I have options. Everyone on this bus has the numbers without the options. I have thought about the difference for eleven days and I am still not able to write a sentence about it that does not make me want to put the pen down.

The woman across the aisle introduces herself before we clear the second switchback. Dovey Marchetti, Prometheus stock, sixty-one, hands folded in her lap in a way I recognize immediately because I have started doing it myself in meetings.

“First time up?” she says.

I tell her yes.

“It’s nice,” she says. “That’s the thing nobody tells you. It’s actually nice.”

She is right. That is the first thing I have to report and the hardest one to explain to anybody who has not been up there. Pellam House is a pre-Upheaval sanatorium, four floors of good stone with a slate roof they have kept in repair, and it looks down a valley that still has water in it. The wards are warm. The laundry is done properly and smells of nothing. The food comes out of a kitchen with two cooks who argue about salt in a way that suggests they have been arguing about salt for years. There are one hundred and sixty residents and thirty-one staff and every one of the staff knows every one of the residents by name and by build.

Intake takes forty minutes. A nurse named Aleks weighs me, draws blood, runs a reflex panel, and asks me eleven questions, of which two are about symptoms. The other nine are about my family. Do I have living parents. Do I have siblings, and do they know where I am. Do I have children. Is there anyone who would need to be notified, and at what address, and does that address have a name on it.

I answer as Renna Cole, who has nobody. Aleks writes it down without a flicker. Then he looks up at me for about a second and a half longer than the form requires, and I watch him decide not to say the thing he has just worked out, and he says, “You’ll be in east ward. Dovey’s on east ward. She’ll look after you.”

He read my label in nine seconds. I have thought about that since, too. He read it, and filed me anyway, and the reason he filed me anyway is in section four of this piece.

The day at Pellam House has a shape. Assay at six. Dose round at six forty. Breakfast until eight. Then what the program calls purposeful activity, which is a phrase I arrived ready to be contemptuous about and left unable to be contemptuous about, because purposeful activity at Pellam House means the garden, the workshop, the kitchen, and the library, and the residents run all four.

The garden is the one that undid me. There are eleven raised beds on the south terrace, built at a height that a person with an unreliable back can work without kneeling, and they are worked every morning by six or seven residents in rotation. On my third day a man named Portz, ex-infantry, Document War vintage, spent an hour teaching me to pinch out tomato side shoots with a hand that was shaking hard enough that he had to brace his wrist against the frame to do it. He got every one of them. It took him an hour. A baseline would have done the bed in nine minutes and taken four of the wrong shoots.

“You go slow, you go right,” he said. “Nobody ever told me that in the service. Would have been useful.”

The workshop repairs things for the valley. Boots, small motors, furniture. There is a genuine business in it, and the money comes back to the house as a resident fund, and the residents vote on what the fund buys. In the eleven days I was there the fund bought a second kiln and a set of proper knives for the kitchen, on a vote that ran twenty minutes past its scheduled end because a woman from the north ward wanted the money to go to the library instead and made a serious argument for it.

The nights are the part I did not expect. East ward is twenty-two beds in a room built for tuberculosis, with very good windows, and after the ten o’clock round it does not go quiet, it goes conversational. People talk across the aisle in the dark the way you do on a transport. On my fourth night I lay there and listened to a man three beds down explain to a woman who had arrived that morning exactly what her first fortnight would feel like, in order, hour by hour, with no comfort anywhere in it, and it was the kindest thing I heard in eleven days.

They talk about their builds constantly, which surprised me. In every other setting I have been in, a room of forged will get through a whole evening without anybody naming a line. Up there it is small talk. What are you. Drought build, forty-four run. Oh, my sister was forty-four run. There is no weight on it, because everyone in the room has arrived at the same destination and the route has stopped being interesting.

What nobody talks about, in eleven days, in twenty-two beds, is the office on the first floor with the filing cabinets in it.

I want you to hold all of that in your head for the rest of this piece. It is not decoration. It is the actual condition of the place. The residents of Pellam House are cared for, they are useful to each other, they are warm, they are fed, and they are among the last people in this world who can reliably obtain a suppression dose that has been made properly, in a plant with inspections, at a concentration that matches the label.

Now I am going to tell you what that costs.

The library is open until eleven and nobody supervises it. On my fifth night I sat in it with a copy of the Continuity Agreement, which residents can request at any time, because Pellam House is scrupulous, and Pellam House being scrupulous is the entire mechanism.

The agreement is nine pages. Eight of them are about dose supply, assay schedule, accommodation, dietary provision, and the resident fund, and they are generous, and they are honored. Page seven, clause eleven, is four sentences long. In exchange for lifetime provision, the resident assigns to the program and its commercial partners the post-stability rights to their genetic template, including the right to produce derivative commercial stock, in perpetuity, without further consideration to the resident or the resident’s surviving family.

Read that again with the intake questionnaire in your other hand. Do you have living parents. Do you have siblings. Do you have children. Is there anyone who would need to be notified.

They are not asking who to call. They are asking who could sue.

I took the agreement to Dovey the next morning in the garden, and I made the mistake of thinking I was bringing her news.

She let me finish. Then she said: “Clause eleven.”

“You know.”

“Everybody knows. It’s on page seven. It’s not hidden, love. Kist won’t hide it, he’s very proud of not hiding it.” She pulled a shoot and looked at it. “I read it in the coach on the way up. I signed it in the office an hour later.”

I asked her why.

“Because the other door is a garage off the Belt and a coin flip on the concentration, and because I had been doing that for four years and I was tired.” She looked at me properly for the first time. “And because it’s me. What they get is me. Somebody’s going to grow a run of me in fifteen years and sell them to a security firm and they’ll all have my hands and none of them will know where the hands came from, and I’ll be dead, and I will have had eleven good years up here with a garden. You want to tell me that’s not a deal? Do the sum for me. Show me your working.”

I asked her whether anybody up there had refused to sign.

“Two, in my time. One went back down on the bus the same afternoon and I do not know what happened to her. The other one is Portz.” She saw my face. “He signed in the end. Took him fourteen months. Kist let him stay the whole fourteen months on a provisional, which is not a thing that exists in the paperwork, and everybody knew it did not exist, and nobody said a word.”

I said that sounded like decency.

“It is decency,” she said. “And at the end of fourteen months of decency he signed, and now they have got him too, and Kist got to be a good man for fourteen months and got the signature anyway. You tell me what to do with that. I have had eleven years on it.”

I did not have the sum. I still do not.

What I had, sitting in the dirt on the south terrace, was the knowledge that I was going to leave on the eleventh day, and that my numbers are also bad, and that when mine get worse I will be met by four people with proposals because my template is bespoke and my template is interesting and somebody will want it enough to be gentle with me about it. Dovey is shelf. Dovey is one of about ninety thousand people produced off the same commercial stock in a nine-year run. There is no market for one of her. There is a market for all of her, once, at the end, in a file.

Dr. Aurel Kist gave me forty minutes in his office on day eight. He is in his sixties, baseline, soft voice, and he has the specific patience of a man who has had this conversation with journalists before and has never once lost it.

His office looks down the valley. There is a photograph on the wall of the house in 2059, before the roof was done, with fourteen residents standing in front of it, and he can name all fourteen, and did, unprompted, when he saw me look at it. Nine of them are dead. He named those too, and when.

I put clause eleven in front of him.

“Yes,” he said. “It funds the house.”

I asked him whether he thought a person signing on the worst day of their life, with one door available, is giving consent or accepting terms.

“Both,” he said. “And I would rather the terms were mine than the alternative, because I have seen the alternative and so have you. You came up on the bus with people who spent years on corridor doses. Ask Portz what his hands were like in 2062. I am not going to pretend this is a beautiful arrangement. I am going to tell you it is the best arrangement currently available to a shelf-stock forged past expiry in this hemisphere, and that I did not design the world in which that is true.”

I said that he had, in a small way, designed the part of it that runs above this valley, and that a man who arranges to be the only door is not offering a choice.

He took that. He did not flinch and he did not perform being wounded. He said: “If a program without clause eleven existed, I would close this house tomorrow and drive them there myself. Show me one. There are four continuity providers with the plant capacity to make dose at this quality and all four of them take template rights, because template rights are the only asset a shelf-stock forged has that anybody wants. That is the sentence you should print. Not the one about me.”

Then he asked to see my print card.

It was not a trap and it was not aggressive. It is a routine request, made of every resident at the eight-day mark, and he made it the way you would ask someone to confirm a spelling. And I sat there in a warm office above a valley with water in it and understood that I had eleven days of these people’s trust in my notebook and a false name on my wrist, and that the only honest thing available to me was to stop.

I told him who I was.

He listened. He did not raise his voice. When I finished, he said, “Aleks flagged you on day one. Sitting down. You lower yourself.” A pause. “We admitted you anyway. Do you want to know why?”

I said I did.

“Because a bespoke lynx with bad numbers and no enrollment is exactly the person clause eleven is written for, and I assumed that sooner or later you were going to need us, and that it would be easier for you if you had already seen the garden.”

On my last morning the dose round changed Dovey’s formulation. It is a routine adjustment. The house does it constantly and it is one of the reasons the house works.

She came out to the terrace afterward and pinched out a side shoot with her right hand, one motion, no brace against the frame, and she stopped and looked at her own hand as if it belonged to somebody she used to know.

Then she started to cry, and she was furious about it, and she said, “Eleven years,” and then she said something I have not been able to get out of my head since, which is: “They can do this. They could always do this.”

I do not know what the new formulation costs the house. I asked, twice, and got an answer about supply agreements both times. I do know that Dovey Marchetti spent eleven years shaking in a place that could have steadied her hand on any morning it chose, and that on the morning it chose she had already signed page seven, and that the two facts sit next to each other on the same terrace in the same good light and nobody up there will connect them out loud.

The bus down leaves at ten past four. There were four of us on it, three staff going off shift and me. Nobody comes down that road with a bag.

I got on with my notebook and my own bad numbers and my bespoke lynx template that four separate people would like to talk to me about, and I looked back up at the house through the rear window as we took the first switchback, and the last thing I saw was the south terrace in the four o’clock light, and Dovey on the end bed, working slowly, holding her own steady right hand in her left one and not doing anything with either of them.

I ran a shop off the Belt from 2053 to 2059. I told myself I was harm reduction. What I was, for most of those six years, was the cheapest option in a nine-block radius, and the difference between those two things is about forty people whose names I can list. So take this in the spirit it is offered, which is a man handing you the exact procedure he used to defeat and telling you where he cut corners.

Not the brand. The compound, the concentration, and the carrier. Write all three on something that is not a device. Most people in this situation know their pen by its color, and the color is the first thing a corridor seller copies, because it is free. A blue Corvid-4 sleeve costs four credits to buy empty and can be pressed to hold anything. If the only identifier you can offer is blue, you are not buying medicine, you are buying blue.

If you do not know your compound, your clinic knows it, and they will tell you over a counter without an appointment. Go and ask before you need to know. Everybody in this article who got hurt got hurt in a hurry.

Write the carrier down as well, not just the active. Two of the standard suppression formulations share an active compound and differ only in carrier, and they are not interchangeable in a body that has been on one of them for years. A corridor seller will tell you they are the same thing, in good faith, because for most of his customers the difference has never announced itself loudly enough to reach him.

A lot number and a plant mark on an intact carton is the only thing in this transaction that can be checked later. It can be checked by you, by a clinic, and by the next person on the corridor if it goes wrong. A seller who will not part with the packaging is telling you the packaging belongs to a different batch, or to a different compound, or to no batch at all.

The price difference between a dose with a carton and a dose without is usually eight to twelve credits. In my shop it was ten. Ten credits was the price I charged for deniability, and about half my customers paid it, and I thought less of the half who did not, which tells you everything about what I was.

Three checks, in this order, before money moves. The seal ring at the head of the pen should be unbroken and should not turn when you hold the body and twist the cap gently. The plunger should have no play at all before it engages, and a repressed housing almost always has two or three millimeters of slack because the press does not reseat the internal stop. And a full pen makes a specific dull sound when you tap the barrel against a knuckle, not a ring. A garage refill rings.

Do all three in front of the seller, slowly. It costs you nothing and it changes what you are to them. Sellers price the people who do not check.

This sounds like a joke about hygiene. It is a fact about supply. A seller carrying meds and food in the same case is not a pharmacy operation, they are moving whatever came off a truck, and what came off the truck was picked by someone who did not know what any of it was. The temperature history on that dose is unknown and the carrier compound in most suppression formulations is temperature sensitive in a way that does not change the color, the viscosity, or the smell.

The corridor knows this rule. The corridor breaks it constantly, because the case with the food in it is the one that is there at nine at night when your hands have started.

Most suppression carriers degrade above about fourteen degrees, slowly, without any visible change. This is the failure nobody sees, because it does not produce a dramatic incident, it produces a dose that is doing seventy percent of its job for six weeks while the person taking it concludes that their drift is accelerating.

You cannot audit a cold chain from a doorway. What you can do is watch the seller’s handling. Does the case have a cold block in it, and is the block actually cold, and does the seller close the case between transactions or leave it open on a warm evening because closing it is annoying. A seller who closes the case every single time in front of forty customers a night is a seller who does that when nobody is watching. This is the cheapest tell in this column and the one I ignored the most, in my own shop, on hot nights, because closing the case is annoying.

Not the night before a job. Not the morning of an assay. Take a new source for the first time on a day where you are in a room with a person who knows what you took, with the carton on the table where a med tech would find it, and with nothing scheduled. A bad batch usually announces itself in four to nine hours and it usually announces itself as nothing much, which is why people take a second dose on top of it and that is where the real damage lives.

Forget the theatrical ones. The seller worth having is the one who is dull, who has been on the same forty meters of corridor for four years, who asks what compound you are on before quoting a price, and who has, at some point, refused to sell you something. That refusal is the entire relationship. A seller who has never once told you no is a seller who does not know what is in the case either.

Pay this person more than you have to. Pay them when you do not need anything. You are not buying a dose from them, you are buying being remembered on a night when the shelf is thin and two people want the same box.

Every rule above is a way of surviving a market that should not exist. None of them get you a dose made in a plant with inspections. The whole procedure is a set of workarounds for the fact that the four organizations with the capacity to make this properly will only sell it to you in exchange for the rights to what you originally were, and that the fifth option is a man on a corridor with a case, and that I was that man, and that I was one of the better ones, and that being one of the better ones was worth about forty people.

Check the seal. Keep the carton. Find the boring seller. And if somebody ever builds a fifth door, walk through it and do not read this column again.

The object in front of me is ninety millimeters by fifty-five and weighs eleven grams. It is a card of pressed board faced on both sides with a cellulose acetate laminate, of the type used for identity documents between roughly 2038 and 2049, and it has a seven millimeter hole punched through the upper left corner. On the face there are four printed rows and a heat-set seal. It smells faintly of the solvent used in the lamination press, which is the only thing about it that has not changed in twenty-three years.

It is a print card. In the language of the facilities that produced them, a wet print record. It is the document that specifies an original gene template, and it was executed by a client and a technician and filed before the person it describes had been grown.

I want to be careful here, because the card is not a birth certificate and everybody outside this trade gets that wrong. A birth certificate records an event that happened. A print card records an intention that preceded the event. The person is downstream. In the contractual language of the period the person is, and I am quoting a 2044 form, the derivative.

What is actually printed on it is less than people expect. Four rows. The first is the lot and run designation, which is the string every commercial-stock forged can recite. The second is the source template reference, an internal index that points at a file which in most cases no longer exists anywhere. The third is the commissioning client, and on roughly a third of surviving cards this row has been overprinted at some later date with a different name, because rights positions moved and the records office of the day updated the card by running it through the press again. The fourth row is the projected stability window.

That fourth row is the warranty. It is nine characters long. It was produced by an engineering estimate with a stated confidence interval that does not appear on the card, because the card had no room for it, and the confidence interval is the single most consequential piece of information ever left off a document in this industry.

There is no name on a print card. There was nobody to name. This is the detail that undoes people when they see one for the first time, and it undoes them more reliably than anything I could write about the contractual language. It is a document about a person with no space on it for a person.

The physical object exists because of an auditor. Between 2041 and 2043 the commercial forging programs were operating at a speed that made the faction inspectorates nervous, and the compromise that emerged was a physical, non-networked, single-copy record for every template lot, held at the producing facility, produced in a format that could be walked into a room and counted. That is why it is a card. Somebody wanted to be able to count them by hand.

Nobody imagined the card would outlive the facility. Nine of the eleven plants that produced cards in that period no longer exist. Their card stock does. It went out in evacuations, in liquidations, in the pockets of records clerks, and in at least three documented cases in a bag carried by a technician who had decided, for reasons that were never entered anywhere, that these particular cards should not burn.

The punch is the part of the object that matters most and the part nobody planned. A card was punched through the corner when the template lot was retired from production, and the punch was done at the facility with whatever press was in the records office. There was no standard. The 2043 to 2047 presses at three of the plants left a distinct internal burr on the exit side of the hole, a raised lip about a tenth of a millimeter, produced by a die that was already worn when it was installed.

That burr is currently the most reliable authentication in the trade, which is an appalling situation and entirely my fault. I published it. I published it because collectors were being defrauded and I thought the disclosure would collapse the counterfeit market. What happened instead is that the counterfeit market spent nine months learning to reproduce a worn die, and the honest half of the authentication business went out of work, and I now spend a great deal of my time examining burrs that are better than the ones I described.

A word on the laminate, because it is where most of my working week goes. The acetate used between 2038 and 2049 was manufactured in four grades, and the grade used for identity documents yellows on a curve that is predictable to within about eighteen months once you account for storage. A card that has spent twenty-three years in a records office drawer and a card that has spent twenty-three years in a coat pocket do not look alike under raking light, and neither of them looks like a card that was laminated last spring in a workshop with a modern press, whatever the operator did to the stock beforehand.

Counterfeiters solved the yellowing four years ago. They solved the pressed-board core three years ago. They solved the heat-set seal last year, which was genuinely impressive work and which I said so about in print, to some criticism. The one thing they had not solved as of eighteen months ago was the punch, and that is why I wrote about the punch, and we have already covered how well that went.

So: who buys these.

Three groups, and the order tells you the whole economy.

The first and largest is institutional. Continuity providers, clinics, and two faction records offices buy print cards to consolidate template holdings, because a card is prima facie evidence of a rights position in a legal environment where the producing facility no longer exists to be asked. A card for a build line with ninety thousand living members is worth what a small building is worth, and there is nothing sentimental about that transaction at any point.

The second is collectors. Baselines, mostly, and a specific sort of bespoke. They frame them. There is an aesthetic argument about the typography and the laminate and the period, and I have heard it made with real feeling by people who have never once considered that the four printed rows describe a living woman in a district they could not find on a map. I authenticate for these clients. I charge them a great deal. I am not going to pretend that this is principled.

The third group is the reason I am writing this piece.

Forged buy their own cards back.

Not often, because they cannot usually afford to, and not successfully, because a card for a live commercial line is an asset that its institutional holder has no reason to release. But it happens, at the edges, through dealers, through people like me. Three times this year I have authenticated a card for a forged buyer and not charged a fee, which is a small enough gesture that I am embarrassed to have mentioned it.

What they buy is not information. They know their build line. Every commercial-stock forged can recite their line, their run, their projected window, and most of them learned all three from a stranger in an unkind tone before they were twenty. There is nothing on the card they do not know.

What they buy is the object. The single physical copy of the thing that was decided about them, out of the hands of the people who decided it and into their own. One woman I did this for, shelf stock, a 2047 line, held the card for a long time and then asked me whether the punch meant her line was retired. I said it did. She said, “Good.” Then she said, “So there won’t be any more of me,” and I said no, not from this, and she put it in her coat and thanked me and left, and I have thought about the word good every day since.

A note on what happens next, because the trade is changing under all of us. The continuity agreements now being signed at stability programs assign post-stability template rights forward. The institutional holders are acquiring live rights by contract now, and have stopped chasing paper out of dead facilities. Within fifteen years the print card will be a historical object and nothing else. The collectors will be delighted. The prices will go up.

And the woman with the 2047 card will still be the only person alive holding the only copy of the decision that produced her, which is a thing almost nobody in this world gets to say, and which will be worth exactly nothing on any market, and which is the only valuation of this object I am prepared to defend.

I have my own card in a drawer in my office. I have not opened the drawer in six years. My editor asked me to explain that in this piece and I have declined, and she has printed the refusal, which I suppose is her way of explaining it for me.

The Vellum Room is on the forty-fourth floor of a clinic tower in New Geneva and it does not look like a clinic, which is the whole proposition. Low light, walnut, a bar with eleven things on it and a menu of forty-one more that do not appear on any list you can hold. Members come here to buy enhancement the way an earlier century bought wine, by the milliliter, discussed quietly with a man in a good jacket who knows what you had last time.

Anneke Sorrel is at the corner table when I arrive, eleven minutes early, with a glass of something pale and untouched in front of her. She is fifty-one, narrow, extremely well dressed in the way that reads as expensive only on the second look, and she is wearing a collar cut high on the left in a heavy dull silk. I clock the collar. I file it under fashion. I am wrong for two hours.

“You want to talk about the letter,” she says, before I have sat down.

I say that I do.

“Everybody wants to talk about the letter. Nobody wants to talk about the eleven thousand people it goes to, which is a shame, because they are much more interesting than a piece of paper.” She turns her glass a quarter turn without drinking from it. “Sit. Order something. They will bring you a card with things on it you should not order.”

The letter, for those who have been lucky enough not to receive one: when a SOMA CONTINENTAL enrollee’s assay history crosses the threshold that the company calls stability transition, they receive a physical letter. It confirms the reading, sets out the revised dose schedule, restates the terms of their continuity agreement, and provides three contact routes for what the document calls forward arrangements. It is two pages. Sorrel has revised it twice in nine years.

“The first version was written by lawyers,” she says. “It opened with the clause reference. You are receiving this letter pursuant to. I read one in 2059 and I went back to my office and I wrote a version that opens with the person’s name and the words this is not an emergency, and it took me fourteen months to get it approved because legal believed the reassurance was a representation.”

I ask whether it is a representation.

“It is true,” she says. “It is not an emergency. It is a transition with a median duration of six years. People kill themselves in the first week, Miss Rand. They kill themselves in the first week because a lawyer opened a letter with a clause reference. I moved eleven words and that number went down by a third and I have the figures and I am extremely proud of it, and I am aware of how that sounds in your magazine.”

Here is the difficulty with Anneke Sorrel, and it is a difficulty for me and not for her. She is not defensive. She does not do the thing that people in her position always do, the pivot to systemic constraint, the my hands are tied. She goes straight at the ugliest part of her own job with a kind of relish, and after about forty minutes I realized the relish is not confidence. It is rehearsal. She has said all of this to herself, at length, many times, in a room.

I put clause eleven to her. The template rights. The derivative commercial stock. The perpetuity.

“Yes,” she says.

I ask whether she thinks a person signs that freely.

“No.” No pause at all. “Nobody signs that freely. There is one door and we built it and we charge admission in the only currency our enrollees have. I am not going to sit here and tell you about informed consent. You would laugh at me and you would be right to.”

I ask her what she would call it, then.

She thinks about that for long enough that the man in the good jacket comes over and she waves him off without looking.

“Rent,” she says. “We are charging rent on the difference between what a district clinic can make and what our plant can make. The difference is real. Our dose is better. Our dose is why a woman in a borough with no water pressure gets eleven more years. And the rent is her template, in perpetuity, and if you asked me to defend the ratio I could not, because there is no ratio. There is a monopoly and a price and both were set by us.”

I pushed on the monopoly, because it is the load-bearing claim and she had put it there herself. Four plants. I asked her what stops a fifth.

“Nothing legal,” she says. “Capital and inspection. You need a sterile line, a validated carrier synthesis, and a cold chain that does not depend on a district staying solvent, and that is the number I would put in front of you if you were an investor and it would end the conversation. Two consortia have tried since 2058. Both got to validation and stopped, and both of them stopped for the same reason, which is that the enrollees who need the dose cannot pay for it and the only thing they have that services the debt is the template. So you arrive at clause eleven from a spreadsheet, independently, every time. That is what I would like people to understand. Nobody in this industry sat in a room and invented that clause because they were wicked. It is what falls out of the arithmetic, and it falls out of the arithmetic every single time anybody runs it, and that is much worse than wickedness because you cannot fire it.”

I said that a thing which falls out of the arithmetic every time is usually a sign the arithmetic is being run with one input fixed, and that the fixed input here is that the dose has to be paid for by the person taking it.

She looked at me for a while.

“Yes,” she said. “And I have said that sentence in two meetings in nine years, and I have watched what happens to the person who says it, and I stopped saying it. Put that in as well.”

Around ten the room fills. This is the part of the evening I had been told about and had not believed. The Vellum Room’s late trade is baseline money buying capability, and it is conducted with a discretion that is entirely about the transaction and not at all about the shame, because there is no shame in the room. A man at the bar orders reflex work the way you would order a second bottle. A woman two tables over is being talked through a night vision package by a consultant with a folder, and she is asking sensible questions about recovery time, and her husband is on his phone.

I say to Sorrel that it is strange to watch baselines buy, by choice, the things her enrollees were built with and are now being billed for.

“It is not strange,” she says. “It is the market working correctly. They pay for the upside. My people were issued the upside and are paying for the downside. Same product. Different position on the contract.” She turns the glass again. “The woman with the folder will have a dose schedule in four years and she will not call it a dose schedule, she will call it a maintenance program, and it will be excellent, and nobody will ever send her a letter.”

She talks about the eleven thousand in a way I have not heard anybody in her industry talk. Not as a cohort. She has read the replies. There is a return address on the letter, a real one, which she fought for and which goes to a desk outside her office, and roughly one in nine people writes back.

“Most of them are practical,” she says. “Dose questions. Can I move, will the schedule follow me. About one in forty is a letter about their life, and those are the ones I answer myself, by hand, and I am four months behind and I will never catch up, and I do not delegate them, and my deputy thinks that is vanity.”

I ask whether it is.

“Probably. It is certainly not efficient.” She turns the glass. “A man wrote to me in 2063 to ask whether the company would want his daughter’s numbers. Second gen, eleven years old, healthy, no enrollment, nothing on any register. He was not accusing me of anything. He genuinely wanted to know, from the person who would know, whether his child was on a list somewhere. I checked. She was not. I wrote back and told him she was not, and I did not tell him the other thing, which is that there is no mechanism preventing her from being, and that if the commercial case ever arrives she will be, and that my letter to him is now the document establishing that we knew she existed.”

I asked her why she checked at all, given what checking created.

“Because he asked me,” she said. “You keep looking for the moment I decided to be this. There is no moment. There is a series of afternoons on which the kind thing and the correct thing pointed in different directions and I picked, and I picked well about half the time, and the half I picked well are in a filing system and the half I did not are in me.”

At half past eleven she takes something from her bag, and the movement is fast and practiced and completely unhidden, and she puts a small dose pen against the left side of her neck, under the collar, and there is a click.

The collar is not fashion. The collar has never been fashion.

She sees me see it. She does not put the pen away quickly and she does not explain. She waits, which I think is a courtesy and which is certainly a test.

I ask the only question available.

“Second gen,” she says. “Both parents commercial stock, different lines. There is no template for me. There is no card. There is nothing in a drawer anywhere that says what I was supposed to be, because nobody ordered me, my parents just had me, which was not encouraged and was not illegal.” She caps the pen. “I present as baseline on a standard scan. I have never corrected anybody. I have a maintenance program.”

I ask whether anyone at SOMA CONTINENTAL knows.

“Two people. Neither of them in this hemisphere.”

I ask why she is telling me.

I asked her the obvious follow-up, which is whether the eleven thousand people receiving her letter would be comforted or enraged to learn that the woman who signs it is on a maintenance program in a lounge on the forty-fourth floor.

“Enraged,” she said. “Correctly. I am not asking them for anything. I am not claiming kinship, I have not earned it, I have a salary and a plant and a legal department and they have a letter. If I lost all of it tomorrow I would still have a better dose than any of them, because I know four people, and knowing four people is the entire difference between my life and theirs.”

She paid. She refused to let me pay, and she did it in a way that made clear she had refused this before and that the refusal was about the magazine rather than about me.

On the way to the lifts she stopped, and said one more thing, and it is the thing I have not been able to file away.

“I have signed four thousand one hundred and nine of those letters. I know the number. There is no reason for me to know the number.”

The lift came. She got in. The collar sat exactly as it had all evening, high on the left, dull silk, beautifully cut, doing the only job it was ever cut to do.

You come into the Marrow from the north end, off the produce road, and the first thing that happens is that somebody prices you.

Not to your face. That is important and it is the thing the corridor is known for. The touts stand in doorways at the north entrance and they watch you walk away from them for about nine meters, and by the time you reach the second junction a number has already gone down the corridor ahead of you. They are reading gait, recovery, shoulder carriage, and the specific way a person’s weight settles on the back foot, and they are extremely good at it, and I was priced three times in four days by three different people who had never seen my face.

The lowest offer was two hundred and forty credits for a reflex package, quoted to me on day three by a boy of about nineteen outside a shop with a good sign. Two hundred and forty is not a price for work. Two hundred and forty is a price for material that cost nothing. I want to be honest that this is the moment the piece turned for me, and that what upset me was not the danger. It was that somebody had looked at the back of me and concluded that I was a person who would take the cheap one.

Nine hundred meters, roughly north to south, running between the old refrigeration warehouses on a strip that had power and water when nothing else in that quarter did. That is the whole geographic explanation for why the Marrow is where it is. Cryo needs current, current needs cooling, and the district that had both in 2049 got the clinics, and then the clinics got the touts, and then the touts got the corridor.

There are, by the count of the trade association that officially does not exist, one hundred and seventy operating premises on it. Perhaps twenty are what you would call clinics. The rest are consult rooms, aftercare beds, dose shops, supply houses, two very good instrument repairers, a laundry that handles the corridor’s surgical linen and knows more about who is doing what than anyone, and a great number of doorways that are simply where a particular person stands.

The touts are the corridor’s first economy and its most misunderstood one. Outsiders assume they work for the clinics. They do not. A tout is an independent broker who is paid a percentage by whichever premises the walk-in ends up at, and the percentages vary by shop, and the whole art of the job is routing a stranger to the highest-paying premises that will not produce a complaint traceable back to you. That constraint is the only consumer protection in nine hundred meters and it is real, because a tout who sends three people to a bad shop stops being able to stand in a doorway.

The boy who quoted me two hundred and forty is called Emeka and he has worked the north entrance for two years. He agreed to talk on the condition that I did not describe what he looks like, which I have honored, and which he asked for in a way that suggested he had thought about it before I arrived.

“Everybody thinks we guess,” he said. “We do not guess. You put your weight on your back foot when you stopped at the junction and you did it twice. That is a person who has been told to stand still for a long time by somebody in a uniform. So, service. Then you looked at the sign on Ifeoma’s door and not at the price card, and people who read signs and not prices are either rich or press.”

I asked which he had decided.

“Press,” he said. “Rich does not walk in from the produce road.”

I asked him about the two hundred and forty, and he stopped enjoying the conversation.

“That is not my price. I quote what the shop tells me to quote. If you want to know why a package is two hundred and forty, ask the shop where the two hundred and forty comes from.” A pause. “I do not send people to that shop. I quoted you because you had been walking around for three days and somebody was going to.”

The clinics are better than they have any right to be. This is the thing that outsiders refuse to believe and that everybody who has walked the corridor will tell you. The rejection rates in the Marrow are lower than at two of the faction programs I have reported on. The surgeons work with salvaged equipment they maintain themselves, they take referrals from each other with a professional courtesy that would embarrass a hospital, and the good ones will turn away work that a licensed facility would happily take and bill for.

I watched a surgeon called Ifeoma refuse a woman on my second afternoon. The woman wanted night vision, she had the money, and Ifeoma spent nine minutes with her hands on the woman’s neck and then said no, and explained why, and then sat with her for another quarter of an hour while the woman cried, and did not charge her for the consult, and walked her to the door.

Then Ifeoma went back inside and worked until four in the morning on material whose origin she will not discuss with me, with you, or with anyone.

The parts bin. Every conversation in the Marrow eventually arrives at the same closed door and stops politely in front of it.

Genetic material for black-market work comes from three places, and everyone in the corridor can recite them: faction surplus that fell off a manifest, salvage from decommissioned programs, and harvest. The first two are common and the third is rare, and the corridor’s entire moral architecture is built on the belief that the third is rare. Ask about any specific batch and you will get faction surplus, delivered pleasantly, with a shrug that is not evasive so much as tired.

I asked a supply house owner named Bode how he verifies provenance. He said, “I look at the documentation.” I asked if the documentation was real. He said, “The documentation is documentation.” That is not a dodge. That is a precise statement about the epistemic conditions of his business, and he knew it was funny, and he laughed, and then he did not laugh.

What the Marrow has instead of provenance is memory. It is a corridor of nine hundred meters where everybody has worked next to everybody for fifteen years, and reputation moves along it faster than a person can walk. A surgeon whose work fails twice is finished. A supply house that moves a bad batch will find the laundry declining its linen within a week, which sounds trivial and is in fact a death sentence, because the laundry is the only place in the corridor that can process to a standard and everybody knows it.

There is no written rule anywhere on the strip. I asked four people to describe the corridor’s standards and got four different accounts, and all four accounts agreed on the same three things, which are that you do not take a walk-in who is already post-op somewhere else without calling the other shop, that you do not sell a dose to somebody who has come out of an aftercare bed in the last twelve hours, and that you do not touch anybody under seventeen for any money at all. That third one was stated to me with more heat than the other two combined, by a man who sells sleeved housings out of a case and would not otherwise strike you as a moralist.

The laundry is run by a woman named Adaeze who has been there since before the clinics, and my strong impression, unprovable, is that she is the actual regulatory authority of the Marrow and that this arrangement suits everyone including the touts.

The dose shops are the corridor’s second economy and the one that actually keeps the lights on. Perhaps thirty premises, most of them a counter and a cold cabinet, and between them they move more product by value in a week than all the surgery on the strip does in a month. This is the part of the Marrow that has nothing to do with modification. It is a pharmacy district for people whose district lists are nine weeks long, and it exists because four plants in this world make suppression dose properly and none of them will sell to a woman in a borough without taking her template first.

Prices on the corridor run between forty and a hundred and ten credits for a compound that costs under nine to manufacture. Every shopkeeper I asked knew the manufacturing figure and quoted it to me unprompted, with the specific bitterness of people who are being blamed for a markup that happens two steps above them.

“I am the last hand it passes through,” Bode said. “So I am the thief. Fine. Go and find the first hand.”

What the corridor does have, and what no district clinic offers, is hours. The shops at the north end are open at four in the morning. A shaking hand does not schedule itself, and the entire difference between the Marrow and the licensed system, in the view of every person I spoke to on the strip, comes down to the fact that one of them is open when it happens and the other one has a list.

At two in the morning the corridor is at its best and its worst. The dose shops are open, the aftercare beds are full, and the north end is loud in a way that is almost festive. There is food. There is very good food, actually, from a woman with a cart who sells to the night shift and who has an arrangement with three clinics about what she will and will not sell to somebody who is twelve hours post-op.

And there are the people waiting. That is what stays with you. Not the surgery, which happens behind doors, and not the touts, who are just salesmen with an unusual product. It is the benches. There are benches the whole length of the Marrow, put there by nobody in particular, and at two in the morning they are full of people who are eleven hours into a wait for a slot, or waiting for somebody who is inside, or waiting because the aftercare bed costs forty credits a night and a bench costs nothing.

I sat on one for two hours on my last night, next to a man named Tunde who was waiting for his sister. He is baseline. She is shelf stock, past expiry, and had come to the Marrow because the district list was nine weeks and her hands had started.

“They say the corridor is dangerous,” he said. “The corridor is not dangerous. The nine weeks is dangerous.”

I asked whether he was worried about the material.

“Every hour,” he said. “And she is inside anyway, and I brought her, and I would bring her again tomorrow.”

He said the last part looking straight ahead down the corridor, at nothing, the way you say a thing you have already had out with yourself at length and lost.

You leave the Marrow at the south end, where the corridor opens onto a junction with actual traffic and the light gets normal again very suddenly. Nobody prices you on the way out. I asked the boy from day three about that on my last morning and he looked at me like I was slow.

“On the way out you already bought,” he said. “Or you did not. Either way you are done. Why would I waste it on you twice?”